Azilsartan Attenuates 3-Nitropropinoic Acid-Induced Neurotoxicity in Rats: The Role of IĸB/NF-ĸB and KEAP1/Nrf2 Signaling Pathways
Neurochemical Research · 2024-04 · 49 (4) · 1017-1033
DOI: 10.1007/s11064-023-04083-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemical Research, online erschienen am 07.01.2024. Verfasst von Hend A Hamouda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El Aini St., Cairo, 11562, Egypt. Hauptthemen laut MEDLINE: Neurotoxicity Syndromes, Neuroprotective Agents, Huntington Disease, Benzimidazoles. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cairo University.
Abstract (Originalsprache)
Huntington’s disease (HD) is an autosomal-dominant neurodegenerative disorder characterized by motor, psychiatric and cognitive symptoms. Injection of 3-nitropropionic acid (3-NP) is a widely used experimental model for induction of HD. The current study aimed to inspect the potential neuroprotective properties of azilsartan (Azil), an angiotensin II type 1 receptor blocker (ATR1), in 3-NP-induced striatal neurotoxicity in rats. Rats were randomly allocated into five groups and treated for 14 days as follows: group I received normal saline; group II received Azil (10 mg/kg, p.o.); group III received 3-NP (10 mg/kg, i.p); group IV and V received Azil (5 or 10 mg/kg, p.o, respectively) 1 h prior to 3-NP injection. Both doses of Azil markedly attenuated motor and behavioural dysfunction as well as striatal histopathological alterations caused by 3-NP. In addition, Azil balanced striatal neurotransmitters levels as evidenced by the increase of striatal gamma-aminobutyric acid content and the decrease of glutamate content. Azil also amended neuroinflammation and oxidative stress via modulating IĸB/NF-ĸB and KEAP1/Nrf2 downstream signalling pathways, as well as reducing iNOS and COX2 levels. Moreover, Azil demonstrated an anti-apoptotic activity by reducing caspase-3 level and BAX/BCL2 ratio. In conclusion, the present study reveals the neuroprotective potential of Azil in 3-NP-induced behavioural, histopathological and biochemical changes in rats. These findings might be attributed to inhibition of ATR1/NF-κB signalling, modulation of Nrf2/KEAP1 signalling, anti-inflammatory, anti-oxidant and anti-apoptotic properties. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El Aini St., Cairo, 11562, Egypt.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El Aini St., Cairo, 11562, Egypt. rabab.sayed@pharma.cu.edu.eg.
- School of Pharmacy, Newgiza University, Giza, Egypt. rabab.sayed@pharma.cu.edu.eg.
Förderung
- Cairo University
Zitieren
APA
Hamouda, H. A., Sayed, R. H., Eid, N. I., & El-Sayeh, B. M. (2024). Azilsartan Attenuates 3-Nitropropinoic Acid-Induced Neurotoxicity in Rats: The Role of IĸB/NF-ĸB and KEAP1/Nrf2 Signaling Pathways. Neurochemical Research, 49(4), 1017-1033. https://doi.org/10.1007/s11064-023-04083-8
Vancouver
Hamouda HA, Sayed RH, Eid NI, El-Sayeh BM. Azilsartan Attenuates 3-Nitropropinoic Acid-Induced Neurotoxicity in Rats: The Role of IĸB/NF-ĸB and KEAP1/Nrf2 Signaling Pathways. Neurochemical Research. 2024;49(4):1017-1033. doi:10.1007/s11064-023-04083-8
BibTeX
@article{Hamouda2024,
author = {Hamouda, Hend A and Sayed, Rabab H and Eid, Nihad I and El-Sayeh, Bahia M},
title = {Azilsartan Attenuates 3-Nitropropinoic Acid-Induced Neurotoxicity in Rats: The Role of IĸB/NF-ĸB and KEAP1/Nrf2 Signaling Pathways},
journal = {Neurochemical Research},
year = {2024},
volume = {49},
number = {4},
pages = {1017--1033},
doi = {10.1007/s11064-023-04083-8}
}
EUVIMED